Experimental animal models and inflammatory cellular changes in cerebral ischemic and hemorrhagic stroke

Neuroscience Bulletin

Volumn 31, Issue 6, 2015, Pages 717-734

  Yan, Tao ^a,b   Chopp, Michael ^b,c   Chen, Jieli ^a,b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b HENRY FORD HOSPITAL   (United States)

^c OAKLAND UNIVERSITY   (United States)

Author keywords

animal model; hemorrhagic stroke; inflammatory cells; ischemic stroke

Indexed keywords

ENDOTHELIN 1; MICROSPHERE;

ANIMAL MODEL; ARTERY LIGATION; BRAIN EMBOLISM; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLIP; ELECTROCOAGULATION; EXPERIMENTAL ANIMAL; HEART VENTRICLE FIBRILLATION; INFLAMMATORY CELL; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; REVIEW; SUBARACHNOID HEMORRHAGE; ANIMAL; COMPLICATION; DISEASE MODEL; INFLAMMATION; PATHOLOGY; PATHOPHYSIOLOGY; STROKE;

ANIMALS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; DISEASE MODELS, ANIMAL; INFLAMMATION; STROKE;

EID: 84948772916     PISSN: 16737067     EISSN: 19958218     Source Type: Journal    
DOI: 10.1007/s12264-015-1567-z     Document Type: Review

References (213)

1. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation 2015, 131: e29–322.
2. Kochanek KD, Murphy SL, Xu J, Arias E. Mortality in the United States, 2013. NCHS Data Brief 2014: 1–8.
3. Liu L, Wang D, Wong KS, Wang Y. Stroke and stroke care in China: huge burden, significant workload, and a national priority. Stroke 2011, 42: 3651–3654.
4. Bacigaluppi M, Comi G, Hermann DM. Animal models of ischemic stroke. Part two: modeling cerebral ischemia. Open Neurol J 2010, 4: 34–38.
5. Hossmann KA. Viability thresholds and the penumbra of focal ischemia. Ann Neurol 1994, 36: 557–565.
6. Kirkman MA, Allan SM, Parry-Jones AR. Experimental intracerebral hemorrhage: avoiding pitfalls in translational research. J Cereb Blood Flow Metab 2011, 31: 2135–2151.
7. Kooijman E, Nijboer CH, van Velthoven CT, Kavelaars A, Kesecioglu J, Heijnen CJ. The rodent endovascular puncture model of subarachnoid hemorrhage: mechanisms of brain damage and therapeutic strategies. J Neuroinflammation 2014, 11: 2.
8. Macrae IM. Preclinical stroke research—advantages and disadvantages of the most common rodent models of focal ischaemia. Br J Pharmacol 2011, 164: 1062–1078.
9. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989, 20: 84–91.
10. Tamura A, Graham DI, McCulloch J, Teasdale GM. Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab 1981, 1: 53–60.
11. Tyson GW, Teasdale GM, Graham DI, McCulloch J. Focal cerebral ischemia in the rat: topography of hemodynamic and histopathological changes. Ann Neurol 1984, 15: 559–567.
12. Koizumi J, Yoshida Y, Nakazawa T, Ooneda G. Experimental studies of ischemic brain edema. 1. A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn J Stroke 1986, 8: 8.
13. Meyer JS, Gotoh F, Tazakiy. Circulation and metabolism following experimental cerebral embolism. J Neuropathol Exp Neurol 1962, 21: 4–24.
14. Kaneko D, Nakamura N, Ogawa T. Cerebral infarction in rats using homologous blood emboli: development of a new experimental model. Stroke 1985, 16: 76–84.
15. Zhang Z, Zhang RL, Jiang Q, Raman SB, Cantwell L, Chopp M. A new rat model of thrombotic focal cerebral ischemia. J Cereb Blood Flow Metab 1997, 17: 123–135.
16. Markgraf CG, Kraydieh S, Prado R, Watson BD, Dietrich WD, Ginsberg MD. Comparative histopathologic consequences of photothrombotic occlusion of the distal middle cerebral artery in Sprague-Dawley and Wistar rats. Stroke 1993, 24: 286–292; discussion 292–283.
17. Ginsberg MD, Busto R. Rodent models of cerebral ischemia. Stroke 1989, 20: 1627–1642.
18. Tamura A, Asano T, Sano K, Tsumagari T, Nakajima A. Protection from cerebral ischemia by a new imidazole derivative (Y-9179) and pentobarbital. A comparative study in chronic middle cerebral artery occlusion in cats. Stroke 1979, 10: 126–134.
19. Sundt TM, Waltz AG. Experimental cerebral infarction: retro-orbital, extradural approach for occluding the middle cerebral artery. Mayo Clin Proc 1966, 41: 159–168.
20. Crowell RM, Marcoux FW, De Girolami U. Variability and reversibility of focal cerebral ischemia in unanesthetized monkeys. Neurology 1981, 31: 1295–1302.
21. Mohamed AA, Gotoh O, Graham DI, Osborne KA, McCulloch J, Mendelow AD, et al. Effect of pretreatment with the calcium antagonist nimodipine on local cerebral blood flow and histopathology after middle cerebral artery occlusion. Ann Neurol 1985, 18: 705–711.
22. Tamura A, Graham DI, McCulloch J, Teasdale GM. Focal cerebral ischaemia in the rat: 2. Regional cerebral blood flow determined by [14C]iodoantipyrine autoradiography following middle cerebral artery occlusion. J Cereb Blood Flow Metab 1981, 1: 61–69.
23. Bolander HG, Persson L, Hillered L, d’Argy R, Ponten U, Olsson Y. Regional cerebral blood flow and histopathologic changes after middle cerebral artery occlusion in rats. Stroke 1989, 20: 930–937.
24. Takagi K, Zhao W, Busto R, Ginsberg MD. Local hemodynamic changes during transient middle cerebral artery occlusion and recirculation in the rat: a [14C]_iodoantipyrine autoradiographic study. Brain Res 1995, 691: 160–168.
25. Chen ST, Hsu CY, Hogan EL, Maricq H, Balentine JD. A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction. Stroke 1986, 17: 738–743.
26. Xi GM, Wang HQ, He G H, Huang CF, Wei GY. Evaluation of murine models of permanent focal cerebral ischemia. Chin Med J (Engl) 2004, 117: 389–394.
27. Coyle P. Middle cereb ral artery occlusion in the young rat. Stroke 1982, 13: 855–859.
28. Brint S, Jacewicz M, Kiessling M, Tanabe J, Pulsinelli W. Focal brain ischemia in the rat: methods for reproducible neocortical infarction using tandem occlusion of the distal middle cerebral and ipsilateral common carotid arteries. J Cereb Blood Flow Metab 1988, 8: 474–485.
29. Iadecola C, Zhang F, Casey R, Nagayama M, Ross ME. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J Neurosci 1997, 17: 9157–9164.
30. Zhang F, Iadecola C. Stimulation of the fastigial nucleus enhances EEG recovery and reduces tissue damage after focal cerebral ischemia. J Cereb Blood Flow Metab 1992, 12: 962–970.
31. Llovera G, Roth S, Plesnila N, Veltkamp R, Liesz A. Modeling stroke in mice: permanent coagulation of the distal middle cerebral artery. J Vis Exp 2014: e51729.
32. Lubjuhn J, Gastens A, von Wilpert G, Bargiotas P, Herrmann O, Murikinati S, et al. Functional testing in a mouse stroke model induced by occlusion of the distal middle cerebral artery. J Neurosci Methods 2009, 184: 95–103.
33. Menzies SA, Hoff JT, Betz AL. Middle cerebral artery occlusion in rats: a neurological and pathological evaluation of a reproducible model. Neurosurgery 1992, 31: 100-106; discussion 106–107.
34. Mies G, Ishimaru S, Xie Y, Seo K, Hossmann KA. Ischemic thresholds of cerebral protein synthesis and energy state following middle cerebral artery occlusion in rat. J Cereb Blood Flow Metab 1991, 11: 753–761.
35. Zhang L, Li YM, Jing YH, Wang SY, Song YF, Yin J. Protective effects of carbenoxolone are associated with attenuation of oxidative stress in ischemic brain injury. Neurosci Bull 2013, 29: 311–320.
36. Dong Y, Song F, Ma J, He X, Amer S, Gu W, et al. Smallanimal PET demonstrates brain metabolic change after using bevacizumab in a rat model of cerebral ischemic injury. Neurosci Bull 2014, 30: 838–844.
37. Rupadevi M, Parasuraman S, Raveendran R. Protocol for middle cerebral artery occlusion by an intraluminal suture method. J Pharmacol Pharmacother 2011, 2: 36–39.
38. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 1986, 17: 472–476.
39. Belayev L, Alonso OF, Busto R, Zhao W, Ginsberg MD. Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model. Stroke 1996, 27: 1616–1622; discussion 1623.
40. Guzel A, Rolz R, Nikkhah G, Kahlert UD, Maciaczyk J. A microsurgical procedure for middle cerebral artery occlusion by intraluminal monofilament insertion technique in the rat: a special emphasis on the methodology. Exp Transl Stroke Med 2014, 6: 6.
41. Carmichael ST. Rodent models offocal stroke: size, mechanism, and purpose. NeuroRx 2005, 2: 396–409.
42. Hata R, Maeda K, Hermann D, Mies G, Hossmann KA. Evolution of brain infarction after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab 2000, 20: 937–946.
43. Moskowitz MA, Lo EH, Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron 2010, 67: 181–198.
44. Chen J, Venkat P, Zacharek A, Chopp M. Neurorestorative therapy for stroke. Front Hum Neurosci 2014, 8: 382.
45. Yan T, Venkat P, Ye X, Chopp M, Zacharek A, Ning R, et al. HUCBCs increase angiopoietin 1 and induce neurorestorative effects after stroke in T1DM rats. CNS Neurosci Ther 2014, 20: 935–944.
46. Zhang ZG, Chopp M. Neurorestorative t herapies for stroke: underlying mechanisms and translation to the clinic. Lancet Neurol 2009, 8: 491–500.
47. Cui X, Chopp M, Zacharek A, Cui Y, Roberts C, Chen J. The neurorestorative benefit of GW3965 treatment of stroke in mice. Stroke 2013, 44: 153–161.
48. Tsuchiya D, Hong S, Kayama T, Panter SS, Weinstein PR. Effect of suture size and carotid clip application upon blood flow and infarct volume after permanent and temporary middle cerebral artery occlusion in mice. Brain Res 2003, 970: 131–139.
49. Barber PA, Hoyte L, Colbourne F, Buchan AM. Temperatureregulated model of focal ischemia in the mouse: a study with histopathological and behavioral outcomes. Stroke 2004, 35: 1720–1725.
50. Mohr JP, Caplan LR, Melski JW, Goldstein RJ, Duncan GW, Kistler JP, et al. The Harvard Cooperative Stroke Registry: a prospective registry. Neurology 1978, 28: 754–762.
51. Taqi MA, Vora N, Callison RC, Lin R, Wolfe TJ. Past, present, and future of endovascular stroke therapies. Neurology 2012, 79: S213–220.
52. Tissue plasminogen activator for acute isch emic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995, 333: 1581–1587.
53. Clark WM, Madden KP, Rothlein R, Zivin JA. R eduction of central nervous system ischemic injury in rabbits using leukocyte adhesion antibody treatment. Stroke 1991, 22: 877–883.
54. de Ley G, Weyne J, Demeester G, Stryckmans K, Goethals P, Leusen I. Streptokinase treatment versus calcium overload blockade in experimental thromboembolic stroke. Stroke 1989, 20: 357–361.
55. Atochin DN, Murciano JC, Gursoy-Ozdemir Y, Kra sik T, Noda F, Ayata C, et al. Mouse model of microembolic stroke and reperfusion. Stroke 2004, 35: 2177–2182.
56. Miyake K, Takeo S, Kaijihara H. Sustained decre ase in brain regional blood flow after microsphere embolism in rats. Stroke 1993, 24: 415–420.
57. Zhang RL, Chopp M, Zhang ZG, Jiang Q, Ewing JR. A rat model of focal embolic cerebral ischemia. Brain Res 1997, 766: 83–92.
58. Ding G, Jiang Q, Li L, Zhang L, Zhang ZG, Panda S, et al. MRI of combination treatment of embolic stroke in rat with rtPA and atorvastatin. J Neurol Sci 2006, 246: 139–147.
59. Busch E, Kruger K, Hossmann KA. Improved model of thromboembolic stroke and rt-PA induced reperfusion in the rat. Brain Res 1997, 778: 16–24.
60. Zhang L, Zhang RL, Jiang Q, Ding G, Chopp M, Zhang ZG. Focal embolic cerebral ischemia in the rat. Nat Protoc 2015, 10: 539–547.
61. Lauer KK, Shen H, Stein EA, Ho KC, Kampine JP, Hudet z AG. Focal cerebral ischemia in rats produced by intracarotid embolization with viscous silicone. Neurol Res 2002, 24: 181–190.
62. Yang Y, Yang T, Li Q, Wang CX, Shuaib A. A new reprod ucible focal cerebral ischemia model by introduction of polyvinylsiloxane into the middle cerebral artery: a comparison study. J Neurosci Methods 2002, 118: 199–206.
63. Molnar L, Hegedus K, Fekete I. A new model for inducin g transient cerebral ischemia and subsequent reperfusion in rabbits without craniectomy. Stroke 1988, 19: 1262–1266.
64. Watanabe O, Bremer AM, West CR. Experimental regional c erebral ischemia in the middle cerebral artery territory in primates. Part 1: Angio-anatomy and description of an experimental model with selective embolization of the internal carotid artery bifurcation. Stroke 1977, 8: 61–70.
65. Lu YM, Tao RR, Huang JY, Li LT, Liao MH, Li XM, et al. P 2X7 signaling promotes microsphere embolism-triggered microglia activation by maintaining elevation of Fas ligand. J Neuroinflammation 2012, 9: 172.
66. Gerriets T, Li F, Silva MD, Meng X, Brevard M, Sotak CH, et al. The macrosphere model: evaluation of a new stroke model for permanent middle cerebral artery occlusion in rats. J Neurosci Methods 2003, 122: 201–211.
67. Zhang AJ, Yu XJ, Wang M. The clinical manifestations and pathophysiology of cerebral small vessel disease. Neurosci Bull 2010, 26: 257–264.
68. Rapp JH, Pan XM, Neumann M, Hong M, Hollenbeck K, Liu J. M icroemboli composed of cholesterol crystals disrupt the blood-brain barrier and reduce cognition. Stroke 2008, 39: 2354–2361.
69. Lam CK, Yoo T, Hiner B, Liu Z, Grutzendler J. Embolus extra vasation is an alternative mechanism for cerebral microvascular recanalization. Nature 2010, 465: 478–482.
70. Caplan LR, Hennerici M. Impaired clearance of emboli (washou t) is an important link between hypoperfusion, embolism, and ischemic stroke. Arch Neurol 1998, 55: 1475–1482.
71. Watson BD, Dietrich WD, Busto R, Wachtel MS, Ginsberg MD. Ind uction of reproducible brain infarction by photochemically initiated thrombosis. Ann Neurol 1985, 17: 497–504.
72. Lee JK, Park MS, Kim YS, Moon KS, Joo SP, Kim TS, et al. Photo chemically induced cerebral ischemia in a mouse model. Surg Neurol 2007, 67: 620–625; discussion 625.
73. Ikeda S, Harada K, Ohwatashi A, Kamikawa Y, Yoshida A, Kawahira K. A new non-human primate model of photochemically induced cerebral infarction. PLoS One 2013, 8: e60037.
74. Labat-gest V, Tomasi S. Photothrombotic ischemia: a minimally i nvasive and reproducible photochemical cortical lesion model for mouse stroke studies. J Vis Exp 2013.
75. Dietrich WD, Ginsberg MD, Busto R, Watson BD. Photochemically i nduced cortical infarction in the rat. 2. Acute and subacute alterations in local glucose utilization. J Cereb Blood Flow Metab 1986, 6: 195–202.
76. Li H, Zhang N, Lin HY, Yu Y, Cai QY, Ma L, et al. Histological, cellular and behavioral assessments of stroke outcomes after photothrombosis-induced ischemia in adult mice. BMC Neurosci 2014, 15: 58.
77. Schmidt A, Hoppen M, Strecker JK, Diederich K, Schabitz WR, Schilling M, et al. Photochemically induced ischemic stroke in rats. Exp Transl Stroke Med 2012, 4: 13.
78. Kleinschnitz C, Braeuninger S, Pham M, Austinat M, Nolte I, Renne T, et al. Blocking of platelets or intrinsic coagulation pathway-driven thrombosis does not prevent cerebral infarctions induced by photothrombosis. Stroke 2008, 39: 1262–1268.
79. Yoshida Y, Dereski MO, Garcia JH, Hetzel FW, Chopp M. Neuronal in jury after photoactivation of photofrin II. Am J Pathol 1992, 141: 989–997.
80. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988, 332: 411–415.
81. Robinson MJ, Macrae IM, Todd M, Reid JL, McCulloch J. Reduction of local cerebral blood flow to pathological levels by endothelin-1 applied to the middle cerebral artery in the rat. Neurosci Lett 1990, 118: 269–272.
82. Virley D, Hadingham SJ, Roberts JC, Farnfield B, Elliott H, Whelan G, et al. A new primate model of focal stroke: endothelin-1-induced middle cerebral artery occlusion and reperfusion in the common marmoset. J Cereb Blood Flow Metab 2004, 24: 24–41.
83. Sharkey J, Ritchie IM, Kelly PA. Perivascular microapplication of end othelin-1: a new model of focal cerebral ischaemia in the rat. J Cereb Blood Flow Metab 1993, 13: 865–871.
84. Fuxe K, Kurosawa N, Cintra A, Hallstrom A, Goiny M, Rosen L, et al. In volvement of local ischemia in endothelin-1 induced lesions of the neostriatum of the anaesthetized rat. Exp Brain Res 1992, 88: 131–139.
85. Mestriner RG, Miguel PM, Bagatini PB, Saur L, Boisserand LS, Baptista P P, et al. Behavior outcome after ischemic and hemorrhagic stroke, with similar brain damage, in rats. Behav Brain Res 2013, 244: 82–89.
86. Nikolova S, Moyanova S, Hughes S, Bellyou-Camilleri M, Lee TY, Bartha R. Endothelin-1 induced MCAO: dose dependency of cerebral blood flow. J Neurosci Methods 2009, 179: 22–28.
87. Horie N, Maag AL, Hamilton SA, Shichinohe H, Bliss TM, Steinberg GK. Mous e model of focal cerebral ischemia using endothelin-1. J Neurosci Methods 2008, 173: 286–290.
88. Hughes PM, Anthony DC, Ruddin M, Botham MS, Rankine EL, Sablone M, et al. Focal lesions in the rat central nervous system induced by endothelin-1. J Neuropathol Exp Neurol 2003, 62: 1276–1286.
89. Ansari S, Azari H, Caldwell KJ, Regenhardt RW, Hedna VS, Waters MF, et al. Endothelin-1 induced middle cerebral artery occlusion model for ischemic stroke with laser Doppler flowmetry guidance in rat. J Vis Exp 2013.
90. Horn M, Schlote W. Delayed neuronal death and delayed neuronal recovery in the human brain following global ischemia. Acta Neuropathol 1992, 85: 79–87.
91. Smith ML, Auer RN, Siesjo BK. The density and distribution of ischemic brain injury in the rat following 2-10 min of forebrain ischemia. Acta Neuropathol 1984, 64: 319–332.
92. Pulsinelli WA, Brierley JB. A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke 1979, 10: 267–272.
93. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 1982, 239: 57–69.
94. Gill R, Foster AC, Woodruff GN. Systemic administration of MK-801 protects agai nst ischemia-induced hippocampal neurodegeneration in the gerbil. J Neurosci 1987, 7: 3343–3349.
95. Kirino T, Tamura A, Sano K. Delayed neuronal death in the rat hippocampus follow ing transient forebrain ischemia. Acta Neuropathol 1984, 64: 139–147.
96. Eklof B, Siesjo BK. The effect of bilateral carotid artery ligation upon acid-bas e parameters and substrate levels in the rat brain. Acta Physiol Scand 1972, 86: 528–538.
97. Pokorny J, Stanek V, Vrana M. Sudden cardiac death thirty years ago and at present. The role of autonomic disturbances in acute myocardial infarction revisited. Physiol Res 2011, 60: 715–728.
98. Kameyama M, Suzuki J, Shirane R, Ogawa A. A new model of bilateral hemispheric isch emia in the rat—three vessel occlusion model. Stroke 1985, 16: 489–493.
99. Siemkowicz E, Gjedde A. Post-ischemic coma in rat: effect of different pre-ischemic blood glucose levels on cerebral metabolic recovery after ischemia. Acta Physiol Scand 1980, 110: 225–232.
100. Siemkowicz E, Hansen AJ. Clinical restitution following cerebral ischemia in hypo-, normo- and hyperglycemic rats. Acta Neurol Scand 1978, 58: 1–8.
101. Lowry OH, Passonneau JV, Hasselberger FX, Schulz DW. Effect of ischemia on known subs trates and cofactors of the glycolytic pathway in brain. J Biol Chem 1964, 239: 18–30.
102. Pulsinelli WA, Levy DE, Duffy TE. Regional cerebral blood flow and glucose metabolism following transient forebrain ischemia. Ann Neurol 1982, 11: 499–502.
103. Panahian N, Yoshida T, Huang PL, Hedley-Whyte ET, Dalkara T, Fishman MC, et al. Attenua ted hippocampal damage after global cerebral ischemia in mice mutant in neuronal nitric oxide synthase. Neuroscience 1996, 72: 343–354.
104. Hua F, Ma J, Li Y, Ha T, Xia Y, Kelley J, et al. The development of a novel mouse model of transient global cerebral ischemia. Neurosci Lett 2006, 400: 69–74.
105. Smith ML, Bendek G, Dahlgren N, Rosen I, Wieloch T, Siesjo BK. Models for studying long-t erm recovery following forebrain ischemia in the rat. 2. A 2-vessel occlusion model. Acta Neurol Scand 1984, 69: 385–401.
106. Atlasi MA, Naderian H, Noureddini M, Fakharian E, Azami A. Morphology of Rat Hippocampal C A1 neurons following modified two and four-vessels global ischemia models. Arch Trauma Res 2013, 2: 124–128.
107. Li LX, Campbell K, Zhao S, Knuckey NW, Meloni BP. The effect of blood pressure (37 vs 45 mm Hg) and carotid occlusion duration (8 vs 10 min) on CA1-4 neuronal damage when using isoflurane in a global cerebral ischemia rat model. Brain Res Bull 2011, 86: 390–394.
108. Sanderson TH, Wider JM. 2-vessel occlusion/hypotension: a rat model of global brain ischemia. J Vis Exp 2013.
109. Sheng H, Laskowitz DT, Pearlstein RD, Warner DS. Characterization of a recovery global cereb ral ischemia model in the mouse. J Neurosci Methods 1999, 88: 103–109.
110. Wellons JC, Sheng H, Laskowitz DT, Mackensen GB, Pearlstein RD, Warner DS. A comparison of strain-related susceptibility in two murine recovery models of global cerebral ischemia. Brain Res 2000, 868: 14–21.
111. McBean DE, Kelly PA. Rodent models of global cerebral ischemia: a comparison of two-vessel occ lusion and fourvessel occlusion. Gen Pharmacol 1998, 30: 431–434.
112. Yonekura I, Kawahara N, Nakatomi H, Furuya K, Kirino T. A model of global cerebral ischemia in C57 BL/6 mice. J Cereb Blood Flow Metab 2004, 24: 151–158.
113. Thal SC, Thal SE, Plesnila N. Characterization of a 3-vessel occlusion model for the induction o f complete global cerebral ischemia in mice. J Neurosci Methods 2010, 192: 219–227.
114. Soriano MA, Sanz O, Ferrer I, Planas AM. Cortical infarct volume is dependent on the ischemic red uction of perifocal cerebral blood flow in a three-vessel intraluminal MCA occlusion/reperfusion model in the rat. Brain Res 1997, 747: 273–278.
115. Dave KR, Della-Morte D, Saul I, Prado R, Perez-Pinzon MA. Ventricular fibrillation-induced cardiac arrest in the rat as a model of global cerebral ischemia. Transl Stroke Res 2013, 4: 571–578.
116. Kofler J, Hattori K, Sawada M, De Vries AC, Martin LJ, Hurn PD, et al. Histopathological and behavio ral characterization of a novel model of cardiac arrest and cardiopulmonary resuscitation in mice. J Neurosci Methods 2004, 136: 33–44.
117. Mizushima H, Zhou CJ, Dohi K, Horai R, Asano M, Iwakura Y, et al. Reduced postischemic apoptosis in the hippocampus of mice deficient in interleukin-1. J Comp Neurol 2002, 448: 203–216.
118. Menzebach A, Bergt S, von Waldthausen P, Dinu C, Noldge- Schomburg G, Vollmar B. A comprehensive study of survival, tissue damage, and neurological dysfunction in a murine model of cardiopulmonary resuscitation after potassiuminduced cardiac arrest. Shock 2010, 33: 189–196.
119. Busto R, Dietrich WD, Globus MY, Valdes I, Scheinberg P, Ginsberg MD. Small differences in intraischem ic brain temperature critically determine the extent of ischemic neuronal injury. J Cereb Blood Flow Metab 1987, 7: 729–738.
120. Anuncibay-Soto B, Perez-Rodriguez D, Llorente IL, Regueiro-Purrinos M, Gonzalo-Orden JM, Fernandez-Lopez A. Agedependent modifications in vascular adhesion molecules and apoptosis after 48-h reperfusion in a rat global cerebral ischemia model. Age (Dordr) 2014, 36: 9703.
121. Appelros P, Stegmayr B, Terent A. Sex differences in stroke epidemiology: a systematic review. Stroke 2009, 40: 1082–1090.
122. Gibson CL. Cerebral ischemic stroke: is gender important? J Cereb Blood Flow Metab 2013, 33: 1355–1361.
123. Liu F, Yuan R, Benashski SE, McCullough LD. Changes in experimental stroke outcome across the life span. J Cereb Blood Flow Metab 2009, 29: 792–802.
124. Murphy SJ, McCullough LD, Smith JM. Stroke in the female: role of biological sex and estrogen. ILAR J 2004, 45: 147–159.
125. Simpkins JW, Yang SH, Wen Y, Singh M. Estrogens, progestins, menopause and neurodegeneration: basic and cli nical studies. Cell Mol Life Sci 2005, 62: 271–280.
126. Vegeto E, Ghisletti S, Meda C, Etteri S, Belcredito S, Maggi A. Regulation of the lipopolysaccharide signal transduction pathway by 17beta-estradiol in macrophage cells. J Steroid Biochem Mol Biol 2004, 91: 59–66.
127. Amantea D, Russo R, Bagetta G, Corasaniti MT. From clinical evidence to molecular mechanisms underlying neuro protection afforded by estrogens. Pharmacol Res 2005, 52: 119–132.
128. Soares R, Guo S, Russo J, Schmitt F. Role of the estrogen antagonist ICI 182,780 in vessel assembly and apopto sis of endothelial cells. Ultrastruct Pathol 2003, 27: 33–39.
129. Dubal DB, Zhu H, Yu J, Rau SW, Shughrue PJ, Merchenthaler I, et al. Estrogen receptor alpha, not beta, is a cri tical link in estradiol-mediated protection against brain injury. Proc Natl Acad Sci U S A 2001, 98: 1952–1957.
130. Ankolekar S, Rewell S, Howells DW, Bath PM. The influence of stroke risk factors and comorbidities on assessment of stroke therapies in humans and animals. Int J Stroke 2012, 7: 386–397.
131. Liu M, Tsuji T, Tsujiuchi K, Chino N. Comorbidities in stroke patients as assessed with a newly developed comorbi dity scale. Am J Phys Med Rehabil 1999, 78: 416–424.
132. Liao SJ, Huang RX, Su ZP, Zeng JS, Mo JW, Pei Z, et al. Stroke-prone renovascular hypertensive rat as an animal mo del for stroke studies: from artery to brain. J Neurol Sci 2013, 334: 1–5.
133. WRITING GROUP MEMBERS, Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, et al. Heart disease and stroke statistics—2010 update: a report from the American Heart Association. Circulation 2010, 121: e46–e215.
134. Yong M, Kaste M. Dynamic of hyperglycemia as a predictor of stroke outcome in the ECASS-II trial. Stroke 2008, 39: 27 49–2755.
135. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and d iabetic patients: a systematic overview. Stroke 2001, 32: 2426–2432.
136. Chen J, Ye X, Yan T, Zhang C, Yang XP, Cui X, et al. Adverse effects of bone marrow stromal cell treatment of stroke i n diabetic rats. Stroke 2011, 42: 3551–3558.
137. Yan T, Ye X, Chopp M, Zacharek A, Ning R, Venkat P, et al. Niaspan attenuates the adverse effects of bone marrow stromal cell treatment of stroke in type one diabetic rats. PLoS One 2013, 8: e81199.
138. Yan T, Chopp M, Ye X, Liu Z, Zacharek A, Cui Y, et al. Niaspan increases axonal remodeling after stroke in type 1 diabet es rats. Neurobiol Dis 2012, 46: 157–164.
139. Ye X, Chopp M, Liu X, Zacharek A, Cui X, Yan T, et al. Niaspan reduces high-mobility group box 1/receptor for advanced gl ycation endproducts after stroke in type-1 diabetic rats. Neuroscience 2011, 190: 339–345.
140. Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation. Nat Med 2011, 17: 796–808.
141. Denes A, Vidyasagar R, Feng J, Narvainen J, McColl BW, Kauppinen RA, et al. Proliferating resident microglia after focal ce rebral ischaemia in mice. J Cereb Blood Flow Metab 2007, 27: 1941–1953.
142. Schilling M, Strecker JK, Schabitz WR, Ringelstein EB, Kiefer R. Effects of monocyte chemoattractant protein 1 on bloodborn e cell recruitment after transient focal cerebral ischemia in mice. Neuroscience 2009, 161: 806–812.
143. del Zoppo GJ. Acute anti-inflammatory approaches to ischemic stroke. Ann N Y Acad Sci 2010, 1207: 143–148.
144. Hallenbeck J M, Dutka AJ, Tanishima T, Kochanek PM, Kumaroo KK, Thompson CB, et al. Polymorphonuclear leukocyte accumulation in brain regions with low blood flow during the early postischemic period. Stroke 1986, 17: 246–253.
145. Amantea D, Tassorelli C, Petrelli F, Certo M, Bezzi P, Micieli G, et al. Understanding the multifaceted role of inflammatory me diators in ischemic stroke. Curr Med Chem 2014, 21: 2098–2117.
146. Matsuo Y, Onodera H, Shiga Y, Nakamura M, Ninomiya M, Kihara T, et al. Correlation between myeloperoxidasequantified neutrophil accumulation and ischemic brain injury in the rat. Effects of neutrophil depletion. Stroke 1994, 25: 1469–1475.
147. Atochin DN, Fisher D, Demchenko IT, Thom SR. Neutrophil sequestration and the effect of hyperbaric oxygen in a rat model of tempo rary middle cerebral artery occlusion. Undersea Hyperb Med 2000, 27: 185–190.
148. Price CJ, Menon DK, Peters AM, Ballinger JR, Barber RW, Balan KK, et al. Cerebral neutrophil recruitment, histology, and outcome i n acute ischemic stroke: an imaging-based study. Stroke 2004, 35: 1659–1664.
149. Tanaka R, Komine-Kobayashi M, Mochizuki H, Yamada M, Furuya T, Migita M, et al. Migration of enhanced green fluorescent protein exp ressing bone marrow-derived microglia/macrophage into the mouse brain following permanent focal ischemia. Neuroscience 2003, 117: 531–539.
150. Wen YD, Zhang HL, Qin ZH. Inflammatory mechanism in ischemic neuronal injury. Neurosci Bull 2006, 22: 171–182.
151. Takata M, Nakag omi T, Kashiwamura S, Nakano-Doi A, Saino O, Nakagomi N, et al. Glucocorticoid-induced TNF receptortriggered T cells are key modulators for survival/death of neural stem/progenitor cells induced by ischemic stroke. Cell Death Differ 2012, 19: 756–767.
152. Li GZ, Zhong D, Yang LM, Sun B, Zhong ZH, Yin YH, et al. Expression of interleukin-17 in ischemic brain tissue. Scand J Immunol 2005, 62: 481–486.
153. Yilmaz G, Arumugam TV, Stokes KY, Granger DN. Role of T lymphocytes and interferon-gamma in ischemic stroke. Circulation 2006, 113: 210 5–2112.
154. Jin R, Yang G, Li G. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol 2010, 87: 779–789.
155. Yilmaz G, Granger DN. Leukocyte recruitment and ischemic brain injury. Neuromolecular Med 2010, 12: 193–204.
156. Shichita T, Sugiyama Y, Ooboshi H, Sugimori H, Nakagawa R, Takada I, et al. Pivotal role of cerebral interleukin-17- producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nat Med 2009, 15: 946–950.
157. Shibata K, Yamada H, Hara H, Kishihara K, Yoshikai Y. Resident Vdelta1+ gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL- 17 production. J Immunol 2007, 178: 4466–4472.
158. Gan Y, Liu Q, Wu W, Yin JX, Bai XF, Shen R, et al. Ischemic neurons recruit natural killer cells that accelerate brain infarction. Proc Natl Acad Sci U S A 2014, 111: 2704–2709.
159. Fu Y, Zhang N, Ren L, Yan Y, Sun N, Li YJ, et al. Impact of an immune modulator fingolimod on acute ischemic stroke. Proc Natl Acad Sci U S A 2014, 111: 18315–18320.
160. Lehmann J, Hartig W, Seidel A, Fuldner C, Hobohm C, Grosche J, et al. Inflammatory cell recruitment after experimental thromboembolic stroke i n rats. Neuroscience 2014, 279: 139–154.
161. Moller K, Boltze J, Posel C, Seeger J, Stahl T, Wagner DC. Sterile inflammation after permanent distal MCA occlusion in hypertensive rats. J Ce reb Blood Flow Metab 2014, 34: 307–315.
162. Chu HX, Kim HA, Lee S, Moore JP, Chan CT, Vinh A, et al. Immune cell infiltration in malignant middle cerebral artery infarction: comparison wit h transient cerebral ischemia. J Cereb Blood Flow Metab 2014, 34: 450–459.
163. Zhou W, Liesz A, Bauer H, Sommer C, Lahrmann B, Valous N, et al. Postischemic brain infiltration of leukocyte subpopulations differs among murine permanent and transient focal cerebral ischemia models. Brain Pathol 2013, 23: 34–44.
164. Bullock R, Mendelow AD, Teasdale GM, Graham DI. Intracranial haemorrhage induced at arterial pressure in the rat. Part 1: Description of technique, ICP changes and neuropathological findings. Neurol Res 1984, 6: 184–188.
165. Nath FP, Jenkins A, Mendelow AD, Graham DI, Teasdale GM. Early hemodynamic changes in experimental intracerebral hemorrhage. J Neurosurg 1986, 65: 697–703.
166. Rosenberg GA, Mun-Bryce S, Wesley M, Kornfeld M. Collagenase-induced intracerebral hemorrhage in rats. Stroke 1990, 21: 801–807.
167. Lopez Valdes E, Hernandez Lain A, Calandre L, Grau M, Cabello A, Gomez-Escalonilla C. Time window for clinical effectiveness of mass evacuation in a rat balloon model mimicking an intraparenchymatous hematoma. J Neurol Sci 2000, 174: 40–46.
168. Mendelow AD. Mechanisms of ischemic brain damage with intracerebral hemorrhage. Stroke 1993, 24: I115–117; discussion I118–119.
169. Funnell WR, Mays inger D, Cuello AC. Three-dimensional reconstruction and quantitative evaluation of devascularizing cortical lesions in the rat. J Neuro sci Methods 1990, 35: 147–156.
170. Kaufman HH, Pruessner JL, Bernstein DP, Borit A, Ostrow PT, Cahall DL. A rabbit model of intracerebral hematoma. Acta Neuropathol 1985, 65: 318–321.
171. Clark W, Gunion-Rinker L, Lessov N, Hazel K. Citicoline treatment for experimental intracerebral hemorrhage in mice. Stroke 1998, 29: 2136–2140.
172. Kobari M, Gotoh F, Tomita M, Tanahashi N, Shinohara T, Terayama Y, et al. Bilateral hemispheric reduction of cerebral blood volume and blood flow immediate ly after experimental cerebral hemorrhage in cats. Stroke 1988, 19: 991–996.
173. Coulter DM, Gooch WM. Falling intracranial pressure: an important element in the genesis of intracranial hemorrhage in the beagle puppy. Biol Neonate 1993, 63: 316–326.
174. Mun-Bryce S, Wilkerson AC, Papuashvili N, Okada YC. Recurring episodes of spreading depression are spontaneously elicited by an intracerebral hemorrhage in t he swine. Brain Res 2001, 888: 248–255.
175. Del Zoppo GJ, Copeland BR, Waltz TA, Zyroff J, Plow EF, Harker LA. The beneficial effect of intracarotid urokinase on acute stroke in a baboon model. Stroke 1986, 17: 638–643.
176. Strbian D, Tatlisumak T, Ramadan UA, Lindsberg PJ. Mast cell blocking reduces brain edema and hematoma volume and improves outcome after experimental intracere bral hemorrhage. J Cereb Blood Flow Metab 2007, 27: 795–802.
177. Xi G, Keep RF, Hoff JT. Erythrocytes and delayed brain edema formation following intracerebral hemorrhage in rats. J Neurosurg 1998, 89: 991–996.
178. Kingman TA, Mendelow AD, Graham DI, Teasdale GM. Experimental intracerebral mass: description of model, intracranial pressure changes and neuropathology. J Neuro pathol Exp Neurol 1988, 47: 128–137.
179. Strbian D, Durukan A, Tatlisumak T. Rodent models of hemorrhagic stroke. Curr Pharm Des 2008, 14: 352–358.
180. Deinsberger W, Vogel J, Kuschinsky W, Auer LM, Bo ker DK. Experimental intracerebral hemorrhage: description of a double injection model in rats. Neurol Res 1996, 1 8: 475–477.
181. Belayev L, Saul I, Curbelo K, Busto R, Belayev A, Zhang Y, et al. Experimental intracerebral hemorrhage in the mouse: histological, behavioral, and hemodynamic char acterization of a double-injection model. Stroke 2003, 34: 2221–2227.
182. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989, 320: 365–376.
183. McArdle JP, Muller HK, Roff BT, Murphy WH. Basal lamina redevelopment in tumours metastatic to brain:an immunoperoxidase study using an antibody to type-IV collagen. Int J Cancer 1984, 34: 633–638.
184. Woo D, Broderick JP. Spontaneous intracerebral hemorrhage: epidemiology and clinical presentation. Neurosurg Clin N Am 2002, 13: 265–279.
185. MacLellan CL, Silasi G, Poon CC, Edmundson CL, Buist R, Peeling J, et al. Intracerebral hemorrhage models in rat: comparing collagenase to blood infusion. J Cereb Blood Flow Metab 2008, 28: 516–525.
186. Krafft PR, Rolland WB, Duris K, Lekic T, Campbell A, Tang J, et al. Modeling intracerebral hemorrhage in mice: injection of autologous blood or bacterial collagenase. J Vis Exp 2012: e4289.
187. Sinar EJ, Mendelow AD, Graham DI, Teasdale GM. Experimental intracerebral hemorrhage: effects of a temporary mass lesion. J Neurosurg 1987, 66: 568–576.
188. Shi Y, Li Z, Zhang S, Xie M, Meng X, Xu J, et al. Establishing a model of supratentorial hemorrhage in the piglet. Tohoku J Exp Med 2010, 220: 33–40.
189. Xue M, DelBigio MR. Comparison of brain cell death and inflammatory reaction in three models of intracerebral hemorrhage in adult rats. J Stroke Cerebrovasc Dis 2003, 12: 152–159.
190. Wang J. Preclinical and clinical research on inflammation after intracerebral hemorrhage. Prog Neurobiol 2010, 92: 463–477.
191. Wang J, Dore S. Inflammation after intrace rebral hemorrhage. J Cereb Blood Flow Metab 2007, 27: 894–908.
192. Graeber MB. Changing face of microglia. Science 2010, 330: 783–788.
193. Gao Z, Wang J, Thiex R, Rogove AD, Heppner FL, Tsirka SE. Microglial activation and intracerebral he morrhage. Acta Neurochir Suppl 2008, 105: 51–53.
194. Zhao F, Hua Y, He Y, Keep RF, Xi G. Minocyclineinduced attenuation of iron overload and brain injury after experimental intracerebral hemorrhage. Stroke 2011, 42: 3587–3593.
195. Leira R, Davalos A, Silva Y, Gil-Peralta A, Tejada J, Garcia M, et al. Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors. Neurology 2004, 63: 461–467.
196. Moxon-Emre I, Schlichter LC. Neutrophil depletion reduces blood-brain barrier breakdown, axon injury, and inflammation after intracerebral hemorrhage. J Neuropathol Exp Neurol 2011, 70: 218–235.
197. Gautier S, Ouk T, Petrault O, Caron J, Bordet R. Neutrophils contribute to intracerebral haemorrhages after treatment with recombinant tissue plasminogen activator following cereb ral ischaemia. Br J Pharmacol 2009, 156: 673–679.
198. Xue M, Del Bigio MR. Intracerebral injection of autologous whole blood in rats: time course of inflammation and cell death. Neurosci Lett 2000, 283: 230–232.
199. Loftspring MC, McDole J, Lu A, Clark JF, Johnson AJ. Intracerebral hemorrhage leads to infiltration of several leukocyte populations with concomitant pathophysiological changes. J C ereb Blood Flow Metab 2009, 29: 137–143.
200. Fu Y, Hao J, Zhang N, Ren L, Sun N, Li YJ, et al. Fingolimod for the treatment of intracerebral hemorrhage: a 2-arm proofof- concept study. JAMA Neurol 2014, 71: 1092–1101.
201. Rolland WB, Lekic T, Krafft PR, Hasegawa Y, Altay O, Hartman R, et al. Fingolimod reduces cerebral lymphocyte infiltration in experimental models of rodent intracerebral hemorrhage. Exp Neurol 2013, 241: 45–55.
202. Munakata M, Shirakawa H, Nagayasu K, Miyanohara J, Miyake T, Nakagawa T, et al. Transient receptor potential canonical 3 inhibitor Pyr3 improves outcomes and attenuates astrogliosis after intracerebral hemorrhage in mice. Stroke 2013, 44: 1981–1987.
203. Tejima E, Zhao BQ, Tsuji K, Rosell A, van Leyen K, Gonzalez RG, et al. Astrocytic induction of matrix metalloproteinase-9 and edema in brain hemorrhage. J Cereb Blood Flow Metab 2007, 2 7: 460–468.
204. Mestriner RG, Saur L, Bagatini PB, Baptista PP, Vaz SP, Ferreira K, et al. Astrocyte morphology after ischemic and hemorrhagic experimental stroke has no influence on the different recov ery patterns. Behav Brain Res 2015, 278: 257–261.
205. Marbacher S, Fandino J, Kitchen ND. Standard intracranial in vivo animal models of delayed cerebral vasospasm. Br J Neurosurg 2010, 24: 415–434.
206. Megyesi JF, Vollrath B, Cook DA, Fin dlay JM. In vivo animal models of cerebral vasospasm: a review. Neurosurgery 2000, 46: 448–460; discussion 460–441.
207. McGirt MJ, Lynch JR, Parra A, Sheng H, Pearlstein RD, Laskowitz DT, et al. Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachn oid hemorrhage. Stroke 2002, 33: 2950–2956.
208. Kuwayama A, Zervas NT, Belson R, Shintani A, Pickren K. A model for experimental cerebral arterial spasm. Stroke 1972, 3: 49–56.
209. Prunell GF, Mathiesen T, Diemer NH, Svendgaard NA. Exper imental subarachnoid hemorrhage: subarachnoid blood volume, mortality rate, neuronal death, cerebral blood flow, and perfusion pressure in three different rat models. Neurosurgery 2003, 52: 165–175; discussion 175–166.
210. Matz PG, Sundaresan S, Sharp FR, Weinstein PR. Induction of HSP70 in rat brain following subarachnoid hemorrhage produced by endovascular perforation. J Neurosurg 1996, 85: 138–145.
211. Murakami K, Koide M, Dumont TM, Russell SR, Tranmer BI, Wellman GC. Subarachnoid hemorrhage induces gliosis and increased expression of the pro-inflammatory cytokine high mobility group box 1 protein. Transl Stroke Res 2011, 2: 72–79.
212. Hanafy KA. The role of microglia and the TLR4 pathway in neuronal apoptosis and vasospasm after subarachnoid hemorrhage. J Neuroinflammation 2013, 10: 83.
213. Chyatte D, Bruno G, Desai S, Todor DR. Inflammation and intracranial aneurysms. Neurosurgery 1999, 45: 1137–1146; discussion 1146–1137.